BioLife Solutions 관리
관리 기준 확인 1/4
BioLife Solutions CEO는 Rod de Greef, Oct2023 에 임명되었습니다 의 임기는 1.08 년입니다. 총 연간 보상은 $ 6.39M, 3.1% 로 구성됩니다. 3.1% 급여 및 96.9% 보너스(회사 주식 및 옵션 포함). 는 $ 1.68M 가치에 해당하는 회사 주식의 0.14% 직접 소유합니다. 1.68M. 경영진과 이사회의 평균 재임 기간은 각각 1.1 년과 16 년입니다.
주요 정보
Rod de Greef
최고 경영자
US$6.4m
총 보상
| CEO 급여 비율 | 3.1% |
| CEO 임기 | 1.1yrs |
| CEO 소유권 | 0.1% |
| 경영진 평균 재임 기간 | 1.1yrs |
| 이사회 평균 재임 기간 | 16yrs |
최근 관리 업데이트
Recent updates
Analysts Have Lowered Expectations For BioLife Solutions, Inc. (NASDAQ:BLFS) After Its Latest Results
Nov 15
Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?
Oct 25Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?
Sep 14Why BioLife Solutions, Inc. (NASDAQ:BLFS) Could Be Worth Watching
Aug 30Investors Appear Satisfied With BioLife Solutions, Inc.'s (NASDAQ:BLFS) Prospects As Shares Rocket 28%
Aug 14BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?
Jun 20A Look At The Fair Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)
Jun 05Revenues Not Telling The Story For BioLife Solutions, Inc. (NASDAQ:BLFS) After Shares Rise 25%
May 14Broker Revenue Forecasts For BioLife Solutions, Inc. (NASDAQ:BLFS) Are Surging Higher
May 13Should You Investigate BioLife Solutions, Inc. (NASDAQ:BLFS) At US$19.54?
May 11Does BioLife Solutions (NASDAQ:BLFS) Have A Healthy Balance Sheet?
Mar 12BioLife Solutions, Inc.'s (NASDAQ:BLFS) Intrinsic Value Is Potentially 64% Above Its Share Price
Feb 19BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Matching Investor Opinion
Dec 19Downgrade: Here's How Analysts See BioLife Solutions, Inc. (NASDAQ:BLFS) Performing In The Near Term
Aug 17Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?
Aug 11Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?
May 06Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?
Feb 22Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?
Jan 10Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?
Dec 10BioLife: What The Future Holds
Oct 19CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$49m |
| Jun 30 2024 | n/a | n/a | -US$64m |
| Mar 31 2024 | n/a | n/a | -US$62m |
| Dec 31 2023 | US$6m | US$199k | -US$66m |
| Sep 30 2023 | n/a | n/a | -US$79m |
| Jun 30 2023 | n/a | n/a | -US$74m |
| Mar 31 2023 | n/a | n/a | -US$141m |
| Dec 31 2022 | US$2m | US$450k | -US$140m |
| Sep 30 2022 | n/a | n/a | -US$106m |
| Jun 30 2022 | n/a | n/a | -US$96m |
| Mar 31 2022 | n/a | n/a | -US$15m |
| Dec 31 2021 | US$1m | US$412k | -US$9m |
| Sep 30 2021 | n/a | n/a | US$5m |
| Jun 30 2021 | n/a | n/a | US$4m |
| Mar 31 2021 | n/a | n/a | -US$20m |
| Dec 31 2020 | US$3m | US$391k | US$2m |
| Sep 30 2020 | n/a | n/a | US$7m |
| Jun 30 2020 | n/a | n/a | US$16m |
| Mar 31 2020 | n/a | n/a | US$39m |
| Dec 31 2019 | US$1m | US$403k | -US$2m |
| Sep 30 2019 | n/a | n/a | -US$32m |
| Jun 30 2019 | n/a | n/a | -US$39m |
| Mar 31 2019 | n/a | n/a | -US$44m |
| Dec 31 2018 | US$490k | US$350k | -US$25m |
| Sep 30 2018 | n/a | n/a | US$1m |
| Jun 30 2018 | n/a | n/a | -US$146k |
| Mar 31 2018 | n/a | n/a | -US$2m |
| Dec 31 2017 | US$520k | US$300k | -US$3m |
보상 대 시장: Rod 의 총 보상 ($USD 6.39M )은 US 시장( $USD 3.20M ).
보상과 수익: 회사가 수익성이 없는 동안 Rod 의 보상이 증가했습니다.
CEO
Rod de Greef (64 yo)
1.1yrs
테뉴어
US$6,387,586
보상
Mr. Roderick de Greef, also known as Rod, serves as Director of BioLife Solutions, Inc. since January 03, 2023 and serves as its Chief Executive Officer & Chairman since October 20, 2023. He had been Presi...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Chairman | 1.1yrs | US$6.39m | 0.14% $ 1.7m | |
| Chief Financial Officer | 3yrs | US$1.70m | 0.27% $ 3.1m | |
| Chief Quality & Operations Officer | less than a year | US$1.12m | 0.34% $ 3.9m | |
| Chairman of Scientific Advisory Board | 4.9yrs | US$1.35m | 0.68% $ 7.9m | |
| Chief Technology Officer | no data | 데이터 없음 | 데이터 없음 | |
| Chief Commercial Officer | no data | US$734.45k | 0.23% $ 2.7m | |
| Chief Human Resources Officer | 3.8yrs | 데이터 없음 | 0.13% $ 1.5m |
1.1yrs
평균 재임 기간
53.5yo
평균 연령
경험이 풍부한 관리: BLFS 의 관리팀은 경험 (평균 재직 기간 1.1 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Chairman | 1.8yrs | US$6.39m | 0.14% $ 1.7m | |
| Chairman of Scientific Advisory Board | no data | US$1.35m | 0.68% $ 7.9m | |
| Member of Scientific Advisory Board | 18.1yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 17.2yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 18.1yrs | 데이터 없음 | 데이터 없음 | |
| Member of the Scientific Advisory Board | no data | US$284.00k | 데이터 없음 | |
| Member of Scientific Advisory Board | 17.2yrs | 데이터 없음 | 데이터 없음 | |
| Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Lead Director | 3.6yrs | US$269.17k | 0.039% $ 454.7k | |
| Independent Director | 3.1yrs | US$250.00k | 0.064% $ 746.4k | |
| Member of Scientific Advisory Board | 16yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 12.8yrs | 데이터 없음 | 데이터 없음 |
16.0yrs
평균 재임 기간
59yo
평균 연령
경험이 풍부한 이사회: BLFS 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 16 년).